SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001102
Filing Date
2024-02-21
Accepted
2024-02-21 17:25:43
Documents
16
Period of Report
2024-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aclarion_8k.htm   iXBRL 8-K 35130
2 AUDITED FINANCIAL STATEMENTS aclarion_ex9901.htm EX-99.1 530200
  Complete submission text file 0001683168-24-001102.txt   844639

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acon-20240221.xsd EX-101.SCH 3788
4 XBRL DEFINITION FILE acon-20240221_def.xml EX-101.DEF 26648
5 XBRL LABEL FILE acon-20240221_lab.xml EX-101.LAB 36765
6 XBRL PRESENTATION FILE acon-20240221_pre.xml EX-101.PRE 25272
17 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k_htm.xml XML 5713
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 24661147
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)